Hyperaldosteronism, Familial, Type II
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
8
|
9
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Spitzoid melanoma
|
disease |
|
Neoplastic Process
|
14
|
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Familial Hyperaldosteronism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Surgically-Created Resection Cavity
|
disease |
|
Acquired Abnormality
|
16
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Malignant Carcinoid Syndrome
|
disease |
Neoplasms
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Pancreatic Endocrine Carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Extensively Drug-Resistant Tuberculosis
|
phenotype |
Infections
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Small Fiber Neuropathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
35
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pain Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
41
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Gastro-enteropancreatic neuroendocrine tumor
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
41
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Desmoplastic Small Round Cell Tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Milroy Disease
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
52
|
18
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Papillary craniopharyngioma
|
disease |
Neoplasms
|
Neoplastic Process
|
65
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Tuberculosis, Multidrug-Resistant
|
disease |
Infections
|
Disease or Syndrome
|
67
|
8
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2017 |
Vegetation
|
disease |
|
Anatomical Abnormality
|
67
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
gliosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
80
|
5
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Early Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
83
|
5
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hyperaldosteronism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
84
|
6
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Body Fat Distribution
|
phenotype |
|
Finding
|
90
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Herpes NOS
|
disease |
Infections
|
Disease or Syndrome
|
114
|
5
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Hyperparathyroidism, Primary
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
115
|
39
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Bulbo-Spinal Atrophy, X-Linked
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
126
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Sentinel node (disorder)
|
disease |
|
Disease or Syndrome
|
130
|
5
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Neurofibromatoses
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
135
|
16
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |